The CHIR98014 mouse sensitization effect of saikosaponin was mainly through enhancing the cisplatin-induced apoptosis, which was accompanied by enhanced activation of caspase 3 and the cleavage of caspase 3 substrate PARP, and was blocked by the caspase inhibitor z-VAD. It is noteworthy that Siha cell, which is a well known cervical cancer cell line resistant

to cisplatin, was significantly sensitized to cisplatin-induced cell death, suggesting that saikosaponins are potent adjuvant that are able to override primary cisplatin selleck compound resistance in cancer. Thus, results from this study reveal a novel function of saikosaponins that adds up the anticancer value of these naturally occurring compounds. Many naturally occurring compounds have been reported to exert anti-cancer effect through Selleck SAHA HDAC ROS induction. For example, d-Limonene, a bioactive food component from citrus, was found to augments the cytotoxic effects of docetaxel through induction of cellular H2O2 [25]. Our finding in this study also showed that both SSa and SSd induced significant cellular ROS accumulation in cancer cells, which substantially contribute to synergistic cytotoxicity in saikosaponin and cisplatin cotreated cell. It was previously found that saikosaponins exhibit antioxidant activity in normal hepatocytes [24]. The reason of discrepancy is currently unclear, but could be explained by differences in cellular contents. Indeed, redox regulating compounds such

as flavonoid luteolin can function as an antioxidant in normal cells while as a pro-oxidant

in cancer cells [26]. It remains to be determined that how distinct redox modulating functions are executed in normal and cancerous condition. Conclusion Our results suggest that saikosaponin-a and -d are potent in sensitizing cancer cells to cisplatin-induced apoptosis through ROS accumulation. Thus, the combination of saikosaponins with cisplatin could increase the therapeutic effect of cisplatin against solid tumors. Acknowledgements This study was supported in part by grants 30772539 and 30973403 from National Natural Science Foundation of China and by a grant from the Scientific Research Foundation for the Returned Overseas Chinese Scholar, State Education Ministry of China. Electronic supplementary material Additional file 1: Figure S1. Saikosaponins PRKACG induce intracellular ROS accumulation in Siha cells, A549 cells, and SKOV3 cells. Siha cells, A549 cells, and SKOV3 cells were treated with saikosaponin-a (10 μM) or saikosaponin-d (2 μM) for 30 min respectively and stained with 5 μM of CM-H2DCFDA. The fluorescent intensities were detected by flow cytometry. (JPEG 46 KB) References 1. Bermejo Benito P, Abad Martinez MJ, Silvan Sen AM, et al.: vivo and in vitro antiinflammatory activity of saikosaponins. Life sciences 1998, 63 (13) : 1147–56.PubMedCrossRef 2. Dang SS, Wang BF, Cheng YA, Song P, Liu ZG, Li ZF: Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats. World J Gastroenterol 2007, 13 (4) : 557–63.PubMed 3.